Additionally, several biomarkers, like VEGF, bFGF, and serum Apelin, have shown correlations with IH size during propranolol treatment, offering a promising avenue for more accurate and quantitative assessments (Park et al., 2020; Chen et al., 2024). Here, APLN is linked to isolated hemihyperplasia.